Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 10Completed 10Recruiting 6Not yet recruiting 3Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Breast 10Thoracic 4Sarcoma 3Genitourinary 3Gynecologic 2Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 2

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoadjuvant Therapy × Gynecologic × Clear all
NCT06752135 2024-12-30

HRCC1

Azienda Policlinico Umberto I

Terminated
97 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00190528 2016-09-22

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer

Japan Clinical Oncology Group

Phase 3 Terminated
200 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡